Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection

Civil Hospices of Lyon

Status: Completed

Conditions: Adverse Drug Event; Bone and Joint Infection; Osteomyelitis

Treatments: Other: mandibular osteomylitis

Study type: Observational

Funder types: Other

Identifiers

NCT03808285

18-334

Details and patient eligibility

About

The aim of this study is to adescription of mandibular osteomylitis in patients having had a treatment by DENOSUMAB. Indeed, one of the adverse effect ot this molecule is to induce mandibular infection.

Enrollment: 13 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients having a mandibular osteomylelitis due to DENOSUMAB

Exclusion criteria

• none

Trial design

13 participants in 1 patient group

mandibular osteomylitis

Description:

description of mandibular osteomylitis due to denosumab

Treatment:

Other: mandibular osteomylitis